PLoS ONE (Jan 2013)

Combined use of waist and hip circumference to identify abdominally obese HIV-infected patients at increased health risk.

  • Trevor O'Neill,
  • Giovanni Guaraldi,
  • Gabriella Orlando,
  • Federica Carli,
  • Elisa Garlassi,
  • Stefano Zona,
  • Jean-Pierre Després,
  • Robert Ross

DOI
https://doi.org/10.1371/journal.pone.0062538
Journal volume & issue
Vol. 8, no. 5
p. e62538

Abstract

Read online

ObjectivesTo determine whether for a given waist circumference (WC), a larger hip circumference (HC) was associated with a reduced risk of insulin resistance, type 2 diabetes (T2D), hypertension and cardiovascular disease (CVD) in HIV-infected patients. A second objective was to determine whether, for a given WC, the addition of HC improved upon estimates of abdominal adiposity, in particular visceral adipose tissue (VAT), compared to those obtained by WC alone.MethodsHIV-infected men (N = 1481) and women (N = 841) were recruited between 2005 and 2009. WC and HC were obtained using standard techniques and abdominal adiposity was measured using computed tomography.ResultsAfter control for WC and covariates, HC was negatively associated with risk of insulin resistance (pConclusionsThe identification of HIV-infected individuals at increased health risk by WC alone is substantially improved by the addition of HC. Estimates of visceral adipose tissue by WC are not substantially improved by the addition of HC and thus variation in visceral adiposity may not be the conduit by which HC identifies increased health risk.